Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Dow
Colorcon
AstraZeneca
McKesson
Express Scripts

Last Updated: January 17, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Crenolanib


Email this page to a colleague

« Back to Dashboard

What is the drug development status for Crenolanib?

Crenolanib is an investigational drug.

There have been 17 clinical trials for Crenolanib. The most recent clinical trial was a Phase 2 trial, which was initiated on June 5th 2018.

The most common disease conditions in clinical trials are Leukemia, Myeloid, Acute, Leukemia, Myeloid, and Leukemia. The leading clinical trial sponsors are Arog Pharmaceuticals, Inc., St. Jude Children's Research Hospital, and The V Foundation for Cancer Research.

There are one hundred and eighty-six US patents protecting this investigational drug and one international patent.

Recent Clinical Trials for Crenolanib
TitleSponsorPhase
Study of Crenolanib vs Midostaurin Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed FLT3 Mutated AMLArog Pharmaceuticals, Inc.Phase 3
Study Investigating the Efficacy of Crenolanib With Chemotherapy vs Chemotherapy Alone in R/R FLT3 Mutated AMLArog Pharmaceuticals, Inc.Phase 3
A Study of Crenolanib With Fludarabine and Cytarabine in Pediatric Patients With Relapsed/Refractory FLT3-Mutated Acute Myeloid LeukemiaArog Pharmaceuticals, Inc.Phase 2

See all Crenolanib clinical trials

Clinical Trial Summary for Crenolanib

Top disease conditions for Crenolanib
Top clinical trial sponsors for Crenolanib

See all Crenolanib clinical trials

US Patents for Crenolanib

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Crenolanib ⤷  Try it Free Peptides and combination of peptides for use in immunotherapy against various tumors IMMATICS BIOTECHNOLOGY GMBH (Tuebingen, DE) ⤷  Try it Free
Crenolanib ⤷  Try it Free Therapeutic uses of selected pyrrolopyrimidine compounds with anti-mer tyrosine kinase activity The University of North Carolina at Chapel Hill (Chapel Hill, NC) ⤷  Try it Free
Crenolanib ⤷  Try it Free Peptides and combination of peptides for use in immunotherapy against various tumors IMMATICS BIOTECHNOLOGIES GMBH (Tuebingen, DE) ⤷  Try it Free
Crenolanib ⤷  Try it Free Human anti-VEGFR-2/KDR antibodies KADMON CORPORATION, LLC (New York, NY) ⤷  Try it Free
Crenolanib ⤷  Try it Free Treatment of myelodysplastic syndromes with 2-O and,or 3-O desulfated heparinoids Cantex Pharmaceuticals, Inc. (Weston, FL) ⤷  Try it Free
Crenolanib ⤷  Try it Free Substituted heteroaryl compounds and methods of use CALITOR SCIENCES, LLC (Newbury Park, CA) SUNSHINE LAKE PHARMA CO., LTD. (Dongguan, Guangdong, CN) ⤷  Try it Free
Crenolanib ⤷  Try it Free Peptides and combination of peptides for use in immunotherapy against various tumors IMMATICS BIOTECHNOLOGIES GMBH (Tuebingen, DE) ⤷  Try it Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Crenolanib

Drugname Country Document Number Estimated Expiration Related US Patent
Crenolanib Argentina AR104113 2035-03-27 ⤷  Try it Free
Crenolanib Argentina AR112781 2035-03-27 ⤷  Try it Free
Crenolanib Australia AU2016239920 2035-03-27 ⤷  Try it Free
Crenolanib Australia AU2018232952 2035-03-27 ⤷  Try it Free
Crenolanib Australia AU2019202561 2035-03-27 ⤷  Try it Free
Crenolanib Australia AU2019222976 2035-03-27 ⤷  Try it Free
Crenolanib Australia AU2020256298 2035-03-27 ⤷  Try it Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Dow
Colorcon
AstraZeneca
McKesson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.